nodes	percent_of_prediction	percent_of_DWPC	metapath
Piperacillin—Hypotonia—Epirubicin—thyroid cancer	0.00638	0.00638	CcSEcCtD
Piperacillin—Angiopathy—Vandetanib—thyroid cancer	0.00613	0.00613	CcSEcCtD
Piperacillin—Local reaction—Epirubicin—thyroid cancer	0.00606	0.00606	CcSEcCtD
Piperacillin—Hypokalaemia—Sorafenib—thyroid cancer	0.006	0.006	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00593	0.00593	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00593	0.00593	CcSEcCtD
Piperacillin—Hypotonia—Doxorubicin—thyroid cancer	0.0059	0.0059	CcSEcCtD
Piperacillin—Malnutrition—Vandetanib—thyroid cancer	0.00588	0.00588	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00581	0.00581	CcSEcCtD
Piperacillin—Local reaction—Doxorubicin—thyroid cancer	0.00561	0.00561	CcSEcCtD
Piperacillin—Eruption—Epirubicin—thyroid cancer	0.00545	0.00545	CcSEcCtD
Piperacillin—Thrombocytosis—Epirubicin—thyroid cancer	0.0054	0.0054	CcSEcCtD
Piperacillin—Neutropenia—Sorafenib—thyroid cancer	0.00533	0.00533	CcSEcCtD
Piperacillin—Convulsion—Vandetanib—thyroid cancer	0.0051	0.0051	CcSEcCtD
Piperacillin—Infestation NOS—Sorafenib—thyroid cancer	0.00508	0.00508	CcSEcCtD
Piperacillin—Infestation—Sorafenib—thyroid cancer	0.00508	0.00508	CcSEcCtD
Piperacillin—Eruption—Doxorubicin—thyroid cancer	0.00505	0.00505	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00503	0.00503	CcSEcCtD
Piperacillin—Arthralgia—Vandetanib—thyroid cancer	0.00501	0.00501	CcSEcCtD
Piperacillin—Thrombocytosis—Doxorubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Piperacillin—Renal failure—Sorafenib—thyroid cancer	0.00499	0.00499	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00497	0.00497	CcSEcCtD
Piperacillin—Stomatitis—Sorafenib—thyroid cancer	0.00495	0.00495	CcSEcCtD
Piperacillin—Jaundice—Sorafenib—thyroid cancer	0.00495	0.00495	CcSEcCtD
Piperacillin—Dry mouth—Vandetanib—thyroid cancer	0.0049	0.0049	CcSEcCtD
Piperacillin—Oedema—Vandetanib—thyroid cancer	0.0048	0.0048	CcSEcCtD
Piperacillin—Epistaxis—Sorafenib—thyroid cancer	0.00479	0.00479	CcSEcCtD
Piperacillin—Nervous system disorder—Vandetanib—thyroid cancer	0.00471	0.00471	CcSEcCtD
Piperacillin—Thrombocytopenia—Vandetanib—thyroid cancer	0.0047	0.0047	CcSEcCtD
Piperacillin—Skin disorder—Vandetanib—thyroid cancer	0.00466	0.00466	CcSEcCtD
Piperacillin—Haemoglobin—Sorafenib—thyroid cancer	0.00458	0.00458	CcSEcCtD
Piperacillin—Haemorrhage—Sorafenib—thyroid cancer	0.00456	0.00456	CcSEcCtD
Piperacillin—Urinary tract disorder—Sorafenib—thyroid cancer	0.0045	0.0045	CcSEcCtD
Piperacillin—Urethral disorder—Sorafenib—thyroid cancer	0.00447	0.00447	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00437	0.00437	CcSEcCtD
Piperacillin—Insomnia—Vandetanib—thyroid cancer	0.00434	0.00434	CcSEcCtD
Piperacillin—Erythema multiforme—Sorafenib—thyroid cancer	0.00431	0.00431	CcSEcCtD
Piperacillin—Flushing—Sorafenib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Piperacillin—Dyspepsia—Vandetanib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Piperacillin—Fatigue—Vandetanib—thyroid cancer	0.00414	0.00414	CcSEcCtD
Piperacillin—Angiopathy—Sorafenib—thyroid cancer	0.00414	0.00414	CcSEcCtD
Piperacillin—Immune system disorder—Sorafenib—thyroid cancer	0.00412	0.00412	CcSEcCtD
Piperacillin—Rigors—Epirubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Piperacillin—Pain—Vandetanib—thyroid cancer	0.00411	0.00411	CcSEcCtD
Piperacillin—Constipation—Vandetanib—thyroid cancer	0.00411	0.00411	CcSEcCtD
Piperacillin—Erythema—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Malnutrition—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00393	0.00393	CcSEcCtD
Piperacillin—Rigors—Doxorubicin—thyroid cancer	0.0038	0.0038	CcSEcCtD
Piperacillin—Abdominal pain—Vandetanib—thyroid cancer	0.0038	0.0038	CcSEcCtD
Piperacillin—Body temperature increased—Vandetanib—thyroid cancer	0.0038	0.0038	CcSEcCtD
Piperacillin—Bone disorder—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Piperacillin—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00369	0.00369	CcSEcCtD
Piperacillin—Anaemia—Sorafenib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Piperacillin—Leukopenia—Sorafenib—thyroid cancer	0.00355	0.00355	CcSEcCtD
Piperacillin—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Piperacillin—Asthenia—Vandetanib—thyroid cancer	0.00344	0.00344	CcSEcCtD
Piperacillin—Bone disorder—Doxorubicin—thyroid cancer	0.00344	0.00344	CcSEcCtD
Piperacillin—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Piperacillin—Pruritus—Vandetanib—thyroid cancer	0.0034	0.0034	CcSEcCtD
Piperacillin—Myalgia—Sorafenib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Piperacillin—Arthralgia—Sorafenib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00336	0.00336	CcSEcCtD
Piperacillin—Hepatocellular injury—Epirubicin—thyroid cancer	0.00336	0.00336	CcSEcCtD
Piperacillin—Injection site reaction—Epirubicin—thyroid cancer	0.00334	0.00334	CcSEcCtD
Piperacillin—Dry mouth—Sorafenib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Piperacillin—Diarrhoea—Vandetanib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Piperacillin—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Piperacillin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00324	0.00324	CcSEcCtD
Piperacillin—Candida infection—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Piperacillin—Shock—Sorafenib—thyroid cancer	0.00319	0.00319	CcSEcCtD
Piperacillin—Nervous system disorder—Sorafenib—thyroid cancer	0.00318	0.00318	CcSEcCtD
Piperacillin—Dizziness—Vandetanib—thyroid cancer	0.00318	0.00318	CcSEcCtD
Piperacillin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00317	0.00317	CcSEcCtD
Piperacillin—Blood urea increased—Epirubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Piperacillin—Skin disorder—Sorafenib—thyroid cancer	0.00315	0.00315	CcSEcCtD
Piperacillin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Piperacillin—Injection site reaction—Doxorubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Piperacillin—Vomiting—Vandetanib—thyroid cancer	0.00305	0.00305	CcSEcCtD
Piperacillin—Ecchymosis—Epirubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Rash—Vandetanib—thyroid cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Dermatitis—Vandetanib—thyroid cancer	0.00302	0.00302	CcSEcCtD
Piperacillin—Headache—Vandetanib—thyroid cancer	0.00301	0.00301	CcSEcCtD
Piperacillin—Candida infection—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00295	0.00295	CcSEcCtD
Piperacillin—Blood urea increased—Doxorubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Piperacillin—Nausea—Vandetanib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Piperacillin—Dyspepsia—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Piperacillin—Phlebitis—Epirubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Piperacillin—Thrombophlebitis—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Piperacillin—Ecchymosis—Doxorubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Piperacillin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Piperacillin—Fatigue—Sorafenib—thyroid cancer	0.00279	0.00279	CcSEcCtD
Piperacillin—Pain—Sorafenib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Constipation—Sorafenib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Vascular purpura—Epirubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Piperacillin—Eczema—Epirubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Piperacillin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Phlebitis—Doxorubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Piperacillin—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Piperacillin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Piperacillin—Urticaria—Sorafenib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Piperacillin—Abdominal pain—Sorafenib—thyroid cancer	0.00256	0.00256	CcSEcCtD
Piperacillin—Body temperature increased—Sorafenib—thyroid cancer	0.00256	0.00256	CcSEcCtD
Piperacillin—Dermatitis bullous—Epirubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Piperacillin—Purpura—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Piperacillin—Vascular purpura—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Piperacillin—Eczema—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Piperacillin—Hypersensitivity—Sorafenib—thyroid cancer	0.00239	0.00239	CcSEcCtD
Piperacillin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Piperacillin—Purpura—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Piperacillin—Asthenia—Sorafenib—thyroid cancer	0.00232	0.00232	CcSEcCtD
Piperacillin—Pruritus—Sorafenib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Piperacillin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Piperacillin—Hypokalaemia—Epirubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Diarrhoea—Sorafenib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Piperacillin—Muscular weakness—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Piperacillin—Dizziness—Sorafenib—thyroid cancer	0.00214	0.00214	CcSEcCtD
Piperacillin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Piperacillin—Eosinophilia—Epirubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Piperacillin—Vomiting—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Piperacillin—Hypokalaemia—Doxorubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Piperacillin—Rash—Sorafenib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Dermatitis—Sorafenib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Piperacillin—Headache—Sorafenib—thyroid cancer	0.00203	0.00203	CcSEcCtD
Piperacillin—Pancytopenia—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Piperacillin—Muscular weakness—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Piperacillin—Neutropenia—Epirubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Eosinophilia—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Piperacillin—Nausea—Sorafenib—thyroid cancer	0.00192	0.00192	CcSEcCtD
Piperacillin—Infestation—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Piperacillin—Infestation NOS—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Piperacillin—Pancytopenia—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Piperacillin—Renal failure—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Piperacillin—Jaundice—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Piperacillin—Stomatitis—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Piperacillin—Neutropenia—Doxorubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Piperacillin—Epistaxis—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Piperacillin—Agranulocytosis—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Piperacillin—Infestation NOS—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Piperacillin—Infestation—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Piperacillin—Renal failure—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Haemoglobin—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Piperacillin—Jaundice—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Piperacillin—Stomatitis—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Piperacillin—Haemorrhage—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Piperacillin—Hepatitis—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Piperacillin—Urinary tract disorder—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Piperacillin—Urethral disorder—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Piperacillin—Epistaxis—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Piperacillin—Agranulocytosis—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Piperacillin—Erythema multiforme—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Piperacillin—Haemoglobin—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Piperacillin—Flushing—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Piperacillin—Haemorrhage—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Piperacillin—Hepatitis—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Piperacillin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Piperacillin—Angiopathy—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Piperacillin—Urethral disorder—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Piperacillin—Immune system disorder—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Piperacillin—Chills—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Piperacillin—Erythema multiforme—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Piperacillin—Erythema—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Piperacillin—Malnutrition—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Piperacillin—Flushing—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Piperacillin—Angiopathy—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Piperacillin—Immune system disorder—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Piperacillin—Chills—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Piperacillin—Erythema—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Malnutrition—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Anaemia—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Leukopenia—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Piperacillin—Convulsion—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Piperacillin—Anaemia—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Piperacillin—Myalgia—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Piperacillin—Arthralgia—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Piperacillin—Dry mouth—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Piperacillin—Leukopenia—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Piperacillin—Oedema—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Piperacillin—Anaphylactic shock—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Piperacillin—Shock—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Piperacillin—Convulsion—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Piperacillin—Nervous system disorder—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Piperacillin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Piperacillin—Skin disorder—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Piperacillin—Hyperhidrosis—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Piperacillin—Arthralgia—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Piperacillin—Myalgia—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Piperacillin—Dry mouth—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Piperacillin—Hypotension—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Piperacillin—Oedema—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Piperacillin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Piperacillin—Shock—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Piperacillin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Piperacillin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Piperacillin—Insomnia—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Piperacillin—Skin disorder—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Piperacillin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Piperacillin—Dyspepsia—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Piperacillin—Hypotension—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Piperacillin—Fatigue—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Piperacillin—Pain—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Constipation—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Piperacillin—Insomnia—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Piperacillin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000979	0.000979	CcSEcCtD
Piperacillin—Dyspepsia—Doxorubicin—thyroid cancer	0.000975	0.000975	CcSEcCtD
Piperacillin—Fatigue—Doxorubicin—thyroid cancer	0.000955	0.000955	CcSEcCtD
Piperacillin—Urticaria—Epirubicin—thyroid cancer	0.000951	0.000951	CcSEcCtD
Piperacillin—Pain—Doxorubicin—thyroid cancer	0.000947	0.000947	CcSEcCtD
Piperacillin—Constipation—Doxorubicin—thyroid cancer	0.000947	0.000947	CcSEcCtD
Piperacillin—Abdominal pain—Epirubicin—thyroid cancer	0.000946	0.000946	CcSEcCtD
Piperacillin—Body temperature increased—Epirubicin—thyroid cancer	0.000946	0.000946	CcSEcCtD
Piperacillin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000906	0.000906	CcSEcCtD
Piperacillin—Hypersensitivity—Epirubicin—thyroid cancer	0.000882	0.000882	CcSEcCtD
Piperacillin—Urticaria—Doxorubicin—thyroid cancer	0.00088	0.00088	CcSEcCtD
Piperacillin—Body temperature increased—Doxorubicin—thyroid cancer	0.000876	0.000876	CcSEcCtD
Piperacillin—Abdominal pain—Doxorubicin—thyroid cancer	0.000876	0.000876	CcSEcCtD
Piperacillin—Asthenia—Epirubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Piperacillin—Pruritus—Epirubicin—thyroid cancer	0.000847	0.000847	CcSEcCtD
Piperacillin—Diarrhoea—Epirubicin—thyroid cancer	0.000819	0.000819	CcSEcCtD
Piperacillin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000816	0.000816	CcSEcCtD
Piperacillin—Asthenia—Doxorubicin—thyroid cancer	0.000795	0.000795	CcSEcCtD
Piperacillin—Dizziness—Epirubicin—thyroid cancer	0.000792	0.000792	CcSEcCtD
Piperacillin—Pruritus—Doxorubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Piperacillin—Vomiting—Epirubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Piperacillin—Diarrhoea—Doxorubicin—thyroid cancer	0.000758	0.000758	CcSEcCtD
Piperacillin—Rash—Epirubicin—thyroid cancer	0.000755	0.000755	CcSEcCtD
Piperacillin—Dermatitis—Epirubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Piperacillin—Headache—Epirubicin—thyroid cancer	0.00075	0.00075	CcSEcCtD
Piperacillin—Dizziness—Doxorubicin—thyroid cancer	0.000732	0.000732	CcSEcCtD
Piperacillin—Nausea—Epirubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Piperacillin—Vomiting—Doxorubicin—thyroid cancer	0.000704	0.000704	CcSEcCtD
Piperacillin—Rash—Doxorubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Piperacillin—Dermatitis—Doxorubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Piperacillin—Headache—Doxorubicin—thyroid cancer	0.000694	0.000694	CcSEcCtD
Piperacillin—Nausea—Doxorubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
